Science Pool

Filling a nick in NIK

Posted by Evotec on Jun 21, 2023 1:51:59 PM

Inhibition of NF-κB inducing kinase (NIK) has been pursued as a promising therapeutic target for autoimmune disorders due to its highly regulated role in key steps of the NF-κB signaling pathway. Previously reported NIK inhibitors from our group were shown to be potent, selective, and efficacious, but had higher human dose projections than desirable for immunology indications. Herein we report the clearance-driven optimization of a NIK inhibitor guided by metabolite identification studies and structure-based drug design. This led to the identification of an azabicyclo[3.1.0] hexanone motif that attenuated in vitro and in vivo clearance while maintaining NIK potency and increasing selectivity over other kinases, resulting in a greater than ten-fold reduction in predicted human dose.

READ NOW

Tags: Medicinal Chemistry, Articles & Whitepapers, ADME/DMPK, In vitro Biology, Immunology & Inflammation

Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1

Posted by Evotec on Mar 7, 2023 12:05:56 PM

Originally presented in Science Translational Medicine, this article co-written with Merck & Co. presents a set of bifunctional HIV therapies, dubbed targeted activator of cell kill (TACK) molecules, that were optimized for simultaneous antiviral activity and selective elimination of infected CD4+ T cells from HIV-1 patients.

READ NOW

Tags: Articles & Whitepapers, Structural Biology & Protein Science, Immunology & Inflammation

Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium Tuberculosis Virulence

Posted by Evotec on Jan 11, 2022 4:36:26 PM

Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis, kills 1.5 to 1.7 million people every year. Macrophages are Mtb’s main host cells and their inflammatory response is an essential component of the host defense against Mtb. However, Mtb is able to circumvent the macrophages’ defenses by triggering an inappropriate inflammatory response. Understanding macrophage interactions with Mtb is crucial to develop strategies to control tuberculosis. The present study aims to determine the inflammatory response transcriptome and miRNome of human macrophages infected with the virulent H37Rv Mtb strain, to identify macrophage genetic networks specifically modulated by Mtb virulence.

LEARN MORE

Tags: Medicinal Chemistry, Articles & Whitepapers, In vitro Biology, Anti-Infectives, Immunology & Inflammation

Prostaglandin E Synthase-1 Inhibitors for Endometriosis Treatment

Posted by Evotec on Mar 11, 2021 8:23:50 PM

Tags: Medicinal Chemistry, Evotec, Women's health, Immunology & Inflammation

Potent and Selective hEP4-R Antagonist for Endometriosis Treatment

Posted by Evotec on Mar 11, 2021 8:13:31 PM

Tags: Medicinal Chemistry, Women's health, Articles & Whitepapers, Hit & Target ID/Validation, Immunology & Inflammation

Discovery of a Potent and Selective P2X4 Inhibitor

Posted by Evotec on Mar 11, 2021 8:08:26 PM

Tags: Medicinal Chemistry, Articles & Whitepapers, Immunology & Inflammation

Inhibition of NF-kB Inducing Kinase in IFNα-accelerated Lupus Nephritis

Posted by Evotec on Mar 5, 2021 5:36:55 PM

Tags: Kidney diseases, Articles & Whitepapers, In vivo Pharmacology, Immunology & Inflammation, Metabolic Disease & Complications

Design, Synthesis & SAR of IL2 Inducible T Cell Kinase Inhibitors

Posted by Evotec on Mar 5, 2021 11:54:08 AM

Tags: Medicinal Chemistry, Respiratory, Articles & Whitepapers, Immunology & Inflammation

NF-κB Inducing Kinase: A Therapeutic Target for Systemic Lupus Erythematosus

Posted by Evotec on Mar 4, 2021 10:32:47 PM

Tags: Articles & Whitepapers, Hit & Target ID/Validation, Immunology & Inflammation

Therapeutic Potential of NADPH Oxidase 1/4 Inhibitors

Posted by Evotec on Mar 4, 2021 10:15:10 PM

Tags: Articles & Whitepapers, In vivo Pharmacology, Immunology & Inflammation